Aqua Bio Technology — Capital/Financing Update 2021

Apr 29, 2021

AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private placement

AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private placement

29.4.2021 16:59:54 CEST | Aqua Bio Technology ASA | Inside information

AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private

placement

Reference is made to the stock exchange announcement by Aqua Bio Technology (the

"Company or ABT") on 15 April 2021 regarding the completion of a private

placement raising gross proceeds of up to approximately NOK 15 million (the

"Private Placement") at a fixed subscription price of NOK 11.45 per new share

(the "Offer Shares") towards Akvakulturpartner AS, an investment company which

focuses on attractive and innovate aquaculture opportunities, and certain other

external investors.

The interest for the Private Placement was high and the Offer Shares were

significantly oversubscribed the same afternoon. The Company values the support

from Akvakulturpartner AS, the other investors who subscribed for the Offer

Shares and the continued support from its shareholders in the Company's ambition

to grow by developing its products.

-The interest in the Private Placement demonstrated that we have confidence in

the market. We are experiencing exciting times at ABT, both in product

development and commercialization of our products, says CEO Espen Kvale of ABT.

The Company's board of directors has today formally resolved to issue the Offer

Shares in the Private Placement pursuant to available board authorizations to

settle the share lending arrangement with shareholder Kjeveortoped Espen Dahls

AS. Such shares will be issued on a separate, non-tradable ISIN, awaiting

approval and publication of a listing prospectus.

For further information, please contact CEO Espen Kvale, telephone +47 9162

* * *

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. ABT's focus on commercialization and development of natural

ingredients and natural skin care products has been, and will continue to be, an

important part of the Company's strategy going forward.

Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock

Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act. The stock exchange announcement

was published by Håvard Lindstrøm, Head of Business Development, on 29 April

2021 at 17.00 CET.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/509/647/Download%20announcement%2

0as%20PDF.pdf